
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2023-04-30 | 2024-04-30 | 2025-04-30 | 2024-04-30 | 2025-04-30 | |
Income Statement | ||||||
Revenue | $161M | $190.4M | $214.7M | $51.3M | $56.5M | |
Gross Profit | $139.4M | $168.5M | $188.5M | $45.6M | $49.7M | |
Operating Income | -$71.2M | -$79.4M | -$75M | -$22.5M | -$18.8M | |
EBITDA | -$65.6M | -$76.8M | -$65.8M | -$20.6M | -$15.9M | |
Diluted EPS | -$1.56 | -$1.64 | -$1.37 | -$0.42 | -$0.33 |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Balance Sheet | ||||||
Current Assets | $83.2M | $245.3M | $225.5M | $218.3M | $214.3M | |
Total Assets | $97.8M | $267M | $249.5M | $242.6M | $247M | |
Current Liabilities | $63.7M | $84.8M | $101.8M | $109.5M | $114.6M | |
Total Liabilities | $95.6M | $92.7M | $108.5M | $113.5M | $120.8M | |
Total Equity | $2.2M | $174.3M | $141M | $129.1M | $126.2M | |
Total Debt | $25M | -- | -- | -- | -- |
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2023-04-30 | 2024-04-30 | 2025-04-30 | 2024-04-30 | 2025-04-30 | |
Cash Flow Statement | ||||||
Cash Flow Operations | -$39.8M | -$18.2M | -$24.2M | $1.6M | -$6.8M | |
Cash From Investing | $31.8M | $8.8M | -$7.2M | $3.7M | $1.4M | |
Cash From Financing | $6.3M | $15.3M | $7.5M | $5.1M | $2.6M | |
Free Cash Flow | -$45.9M | -$22.6M | -$28.1M | $564K | -$8.6M |
Couchbase Inc provides a modern cloud database that offers the robust capabilities required for business-critical applications on a scalable and available platform. It empower developers and architects to build, deploy and run mission-critical applications. Couchbase delivers a high-performance, flexible and scalable modern database that runs across the data center and any cloud. Geographically, the company generates a majority of its revenue from the United States.
In the current month, BASE has received 4 Buy ratings 9 Hold ratings, and 0 Sell ratings. The BASE average analyst price target in the past 3 months is $23.79.
According to analysts, the consensus estimate is that Couchbase share price will drop to $23.79 per share over the next 12 months.
Analysts are divided on their view about Couchbase share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Couchbase is a Sell and believe this share price will rise from its current level to $20.00.
The price target for Couchbase over the next 1-year time period is forecast to be $23.79 according to 13 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 9 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Couchbase is a Hold. 9 of 13 analysts rate the stock a Hold at this time.
You can purchase shares of Couchbase via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Couchbase shares.
Couchbase was last trading at $24.23 per share. This represents the most recent stock quote for Couchbase. Yesterday, Couchbase closed at $24.26 per share.
In order to purchase Couchbase stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.